Restart Life Sciences Corp. NMLSF
Set alert
0.02 USD 0.00 +7.04%
At close · Nov 2
0.05165 Day range 0.05165
0.0101 52-week range 0.12422
- YTD
- -82.42%
- 1 year
- -79.88%
- Open
- 0.05165
- Prev close
- 0.0142
- Mkt cap
- 950.10K
- Vol
- 10
- Avg vol
- 578
- EPS
- -0.02
- P/E
- 0.00
More statistics
- Low
- 0.05165
- High
- 0.05165
2Y chart
Events in this range
- Nov 8, 2024Split: 1 for 5
- Jan 24, 2025Split: 1 for 2
Signals (157)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| RSI: Overbought | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
Newest 20 of 157.
News
- Restart Life Advances Licensed Intellectual Property Portfolio Toward Commercial Launch
- Restart Life Sciences Launches HC Protein+ Products Online and Advances AI-Driven E-Commerce Strategy
- Holy Crap Foods to Exhibit at CHFA NOW Toronto, Debuting New Protein SKUs and Interactive AI Photo Experience
- Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth
- Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
- Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line
- Restart Life Sciences Announces Strategic Focus on Targeted M&A Expansion in Health and CPG Sectors
- Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods
- Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
- Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap
Your note
Sign in to keep a note on NMLSF — it syncs with the Stock Master app.